Preclinical studies indicate that invasive VNS can attenuate neuroinflammation and reduce cerebral infarction volume following stroke through activation of α7 nicotinic acetylcholine receptors (α7nAChR) [16, 17, 18]. Here, CHRNA7 is linked to stroke disorder.